The beneficial effect of tirzepatide on hsCRP, a biomarker of systemic inflammation, YKL-40, a proinflammatory cytokine, and ICAM-1, a biomarker of endothelial dysfunction, was already detectable at 4 weeks, consistent with the salutary effects of GIP and GLP-1 on inflammation and atherosclerosis in experimental models [84,85,86]
[7] [3] Esta diferencia puede relacionarse con las dosis ms altas utilizadas para el manejo de peso (hasta 2.4 mg semanales) comparadas con las dosis para diabetes (tpicamente 0.5-1 mg semanales, con una dosis de 2 mg tambin aprobada para Ozempic)
Label Like a Pro: Your reconstituted vial needs a new label
GIP activation: Enhances insulin sensitivity, works synergistically with GLP-1 on appetite centers
GLP-1 medications are part of a class known as GLP-1 receptor agonists
How Cagrilintide Works Cagrilintide is a long-acting amylin analog